KPCB XV Associates, LLC - Q2 2022 holdings

$54.2 Million is the total value of KPCB XV Associates, LLC's 4 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was - .

 Value Shares↓ Weighting
No holdings reported for quarter Q2 2022
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-07-21
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Twilio Inc.8Q3 202254.3%
Rapt Therapeutics, Inc.8Q3 202243.7%
Atara Biotherapeutics, Inc.8Q3 202227.0%
Upstart Holdings, Inc.3Q2 202142.4%
Augmedix, Inc.2Q2 20220.0%

View KPCB XV Associates, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2022-10-26
13F-HR2022-07-21
13F-HR2022-05-13
13F-HR2022-02-14
13F-HR2021-10-25
13F-HR2021-07-28
13F-HR2021-05-13
13F-HR2021-02-16
42020-10-20
42020-09-11

View KPCB XV Associates, LLC's complete filings history.

Compare quarters

Export KPCB XV Associates, LLC's holdings